News|Articles|February 21, 2024
Upstream Intensification – Enabling Perfusion Processes with Cell Retention Technologies
Author(s)Millipore Sigma
This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
5
